To our knowledge, this is the initial investigation utilizing high-throughput genomic sequencing to analyze the mutational patterns of BRCA1 and BRCA2 in both tissue and blood samples of Egyptian CRC patients. Here, BRCA2 is linked to colorectal carcinoma.